45
CollPlant Biotechnologies closes $9.25M raise in Israel-based biotech
Company raise · Closed · Offering $9.2M · Sold $9.2M · Rehovot, Ireland · filed 2026-10-22
Placement agent engaged
45
CollPlant Biotechnologies Ltd raises $4M under Reg D
Company raise · Closed · Rehovot, Ireland · Form D filed 2026-02-17
Placement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Yehiel Tal | Chief Executive Officer and Interim Chairman of the Board of Directors |
| Jasmine Seror | Vice President, Product Development |
| Eran Rotem | Deputy Chief Executive Officer and Chief Financial Officer |
| Bowman Bagley | Vice President, Commercial North America |
| Alisa Lask | Director |
| Abraham Havron | Director |
| Elan Penn | Director |
| Oren Fahimipoor | Vice President, Operations |
| Bar Abelis | Vice President, Legal |
| Joseph Zarzewsky | Director |
| Philippe Bensimon | Vice President, Regulatory Affairs and Quality Assurance |
| Hugh Evans | Director |
Signed by Eran Rotem, Deputy Chief Executive Officer and Chief Financial Officer.
Placement agents / sales compensation: H.C. Wainwright & Co. LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
52
CollPlant Biotechnologies Ltd raises $10.4M under Reg D
Company raise · Closed · Offering $10.4M · Sold $10.4M · Rehovot, Ireland · filed 2026-07-20
Placement agent engaged
50
CollPlant Biotechnologies Ltd raises $3.9M under Reg D
Company raise · Closed · Offering $3.9M · Sold $3.9M · Rehovot, Ireland · filed 2025-06-04
Placement agent engaged